Born 1956
Member of the board since 2020
BACKGROUND
Svein Mathisen has more than 30 years of experience from management, business development and finance issues in the Life Science industry but also in the global chemical industry. He worked as CEO for twelve years at the listed pharmaceutical company, BioInvent International. Previously, he worked in leading positions within Norsk Hydro ASA. a in Life Science.
EDUCATION
Master of Science in Engineering Physics, Norwegian University of Technology, NTH, Trondheim, Norway
Business Economics and Financial Analysis: Seven one-week modules, Internal Education Norsk Hydro
OTHER ASSIGNMENTS
Board member Balticgruppen Bio AB/Betagenon AB, Genagon Therapeutic AB and Arild Capital AB.
Number of Shares (As of May 11th 2022)
22 500
Independent of the Company, its senior executives and major shareholders
